Nokea
A patient is receiving digoxin as treatment for heart failure. Which of the following would be most important for the nurse to monitor to reduce the risk for toxicity?
- A. Seizure activity
- B. Drug blood level
- C. Urinary output
- D. Blood pressure
Correct Answer: B
Rationale: The nurse should monitor the patient's blood level of the drug to ensure that the level remains within the therapeutic range. Monitoring seizure activity, urination frequency, and blood pressure will not prevent toxicity. Seizure activity is unrelated to digoxin or heart failure.
You may also like to solve these questions
Which statement best describes drug efficacy/toxicity in pediatric patients?
- A. Drug requirements for infants have been extensively studied.
- B. Drug dosage is altered by age and weight in children.
- C. Children always need smaller doses of medication than adults.
- D. Infants and children are not at risk for drug toxicity if the dosage is correct
Correct Answer: B
Rationale: Pediatric dosing adjusts for age and weight due to varying metabolism and body composition.
Which of the following medications has not hypoglycemic effect:
- A. Insulin
- B. Glucagon
- C. Metformin
- D. Glibenclamid
Correct Answer: B
Rationale: Glucagon raises blood glucose levels, unlike the others which lower it.
The treatment of hyperlipidemia with gemfibrozil plus lovastatin is associated with a high risk of:
- A. Constipation
- B. Myopathy
- C. Hepatitis
- D. Thrombocytopenia
Correct Answer: B
Rationale: Combining gemfibrozil and statins increases the risk of myopathy due to elevated statin levels.
A client has an order to receive 10 units of intermediate-acting insulin at bedtime via subcutaneous injection. The nurse would expect to administer the injection at which site? Select one that does not apply.
- A. Upper arm
- B. Inner forearm
- C. Upper abdomen
- D. Upper thigh
Correct Answer: B
Rationale: The sites for subcutaneous injection are the upper arms, the upper abdomen, and the upper thighs.
The current recommended first line treatment of severe malaria in Kenya is?
- A. Quinine
- B. Fansidar
- C. Artescinate
- D. Artemether - lumefantrine
Correct Answer: C
Rationale: Artesunate (often misspelled as Artescinate) is the recommended first-line treatment for severe malaria in Kenya per WHO and national guidelines, administered IV or IM, followed by oral therapy.